MedTrace Logo

The Treatment of Tinnitus With Transcutaneous Non-invasive Vagus Nerve Stimulation

NCT01176734 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2013-04-30

No results posted yet for this study

Summary

The t-VNS STv3 device is a non-invasive, transcutaneous neurostimulator for influencing the afferent branches of the nervus vagus around the human ear. The clinical trial is designed as a a pilot study addressing the treatment of tinnitus with transcutaneous vagus nerve stimulation.

Conditions

  • Tinnitus

Interventions

DEVICE

tVNS-Device

Active treatment with the t-VNS device.

Sponsors & Collaborators

  • cerbomed GmbH

    lead INDUSTRY

Principal Investigators

  • Berthold Langguth, MD · University of Regensburg

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2012-07-31
Completion
2013-03-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01176734 on ClinicalTrials.gov